Company Valuation: ResMed, Inc.

Data adjusted to current consolidation scope
Fiscal Period: June 2020 2021 2022 2023 2024 2025 2026 2027
Capitalization 1 27,776 35,903 30,691 32,133 28,117 35,037 - -
Change - 29.26% -14.52% 4.7% -12.5% 24.61% - -
Enterprise Value (EV) 1 28,489 36,263 31,192 33,346 28,585 34,707 33,833 32,738
Change - 27.29% -13.98% 6.9% -14.28% 21.41% -2.52% -3.24%
P/E ratio 45x 76.1x 39.6x 35.9x 27.7x 26.2x 23.7x 21.6x
PBR 11.1x 12.4x 9.35x 7.76x 5.78x 6.1x 5.14x 4.33x
PEG - -3.2x 0.6x 2.4x 2x 0.8x 2.2x 2.22x
Capitalization / Revenue 9.39x 11.2x 8.58x 7.61x 6x 6.85x 6.35x 5.9x
EV / Revenue 9.63x 11.3x 8.72x 7.9x 6.1x 6.79x 6.13x 5.52x
EV / EBITDA 29.5x 33.8x 26.8x 25.3x 18.1x 18.7x 16.8x 14.9x
EV / EBIT 35.1x 40.1x 31.2x 27.2x 19.3x 20.1x 17.8x 15.8x
EV / FCF 40.3x 57.2x 144x 58.1x 22x 26.7x 22.6x 20.3x
FCF Yield 2.48% 1.75% 0.69% 1.72% 4.55% 3.74% 4.43% 4.92%
Dividend per Share 2 1.56 1.56 1.68 1.8 1.92 2.179 2.52 2.519
Rate of return 0.81% 0.63% 0.8% 0.82% 1% 0.91% 1.06% 1.06%
EPS 2 4.27 3.24 5.3 6.09 6.92 9.1 10.08 11.06
Distribution rate 36.5% 48.1% 31.7% 29.6% 27.7% 24% 25% 22.8%
Net sales 1 2,957 3,197 3,578 4,223 4,685 5,114 5,519 5,935
EBITDA 1 966 1,074 1,162 1,317 1,576 1,856 2,017 2,194
EBIT 1 811.2 903.7 1,000 1,224 1,478 1,729 1,901 2,078
Net income 1 621.7 474.5 779.4 897.6 1,021 1,348 1,490 1,645
Net Debt 1 713 360.1 501.5 1,213 468.9 -329.9 -1,204 -2,299
Reference price 2 192.00 246.52 209.63 218.50 191.42 238.56 238.56 238.56
Nbr of stocks (in thousands) 144,668 145,640 146,405 147,062 146,884 146,867 - -
Announcement Date 8/5/20 8/5/21 8/11/22 8/3/23 8/1/24 - - -
1USD in Million2USD
Estimates

P/E ratio, Detailed evolution

Add to a list
P/E ratio (N) EV / Sales (N) EV / EBITDA (N) Yield (N) Capi.($)
26.04x6.74x18.57x0.92% 34.8B
35.1x5.71x22.68x0.26% 219B
84.7x20.94x50.58x-.--% 208B
79.15x9.87x33.25x-.--% 155B
36.94x6.83x21.74x0.55% 149B
26.35x3.14x14.84x2.02% 65.07B
23.33x7.33x18.89x2.64% 41.68B
30.49x6.4x21.05x-.--% 41.49B
30.19x6.29x21.41x0.68% 41.43B
21.27x2.31x12.4x0.13% 40.04B
Average 39.36x 7.56x 23.54x percentage-no-prefix 99.48B
Weighted average by Cap. 50.28x 9.56x 28.67x percentage-no-prefix
See all sector valuations

Year-on-year evolution of the PER

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Equities
  3. RMD Stock
  4. Valuation ResMed, Inc.